Holista Colltech Limited (ASX:HCT)

Australia · Delayed Price · Currency is AUD

0.0430

0.00 (0.00%)

Sep 25, 2026, 2:12 PM AEST

Market Cap	15.82M -51.8%
Revenue (ttm)	5.89M +0.8%
Net Income	-3.22M
EPS	-0.01
Shares Out	367.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,598
Open	0.0420
Previous Close	0.0430
Day's Range	0.0420 - 0.0430
52-Week Range	0.0420 - 0.0970
Beta	1.28
Analysts	n/a
Price Target	n/a
Est. Earnings	Dec 1, 2026

About Holista Colltech

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it offers GI LiTE, a premix glycemic ... [Read more]

Industry Packaged Foods

Sector Consumer Staples

CEO Leong Loong

Employees 58

Stock Exchange Australian Securities Exchange

Ticker Symbol HCT

Full Company Profile

Financial Performance

In 2025, Holista Colltech's revenue was 5.79 million, an increase of 3.08% compared to the previous year's 5.61 million. Losses were -948,921, 1026.8% more than in 2024.

Financial Statements